Jeff Yass’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Jeff Yass’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,412	Closed	-$669	–	13817
2025 Q4	$669	Sell	11,412 -30,755	-73%	-$3.07K	﹤0.01%	12162
2025 Q3	$3.37K	Buy	+42,167	New	+$3.58K	﹤0.01%	12148
2024 Q2	–	Sell	-13,436	Closed	-$2.42K	–	12862
2024 Q1	$2.42K	Buy	+13,436	New	+$1.97K	﹤0.01%	11980
2022 Q3	–	Sell	-15,678	Closed	-$2K	–	13827
2022 Q2	$2K	Buy	+15,678	New	+$7.68K	﹤0.01%	12688
2020 Q2	–	Sell	-21,017	Closed	-$1K	–	10657
2020 Q1	$1K	Sell	21,017 -9,610	-31%	-$1.16K	﹤0.01%	10136
2019 Q4	$5K	Buy	30,627 +1,000	+3%	+$182	﹤0.01%	9577
2019 Q3	$5K	Hold	29,627	–	–	﹤0.01%	10047
2019 Q2	$7K	Buy	29,627 +1,459	+5%	+$258	﹤0.01%	10093
2019 Q1	$5K	Hold	28,168	–	–	﹤0.01%	8677
2018 Q4	$11K	Buy	+28,168	New	+$9.76K	﹤0.01%	8737

Other funds holding NRXPW

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Jeff Yass's NRXPW Position: Q1 2026 in Review

Jeff Yass sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q1 2026, closing a stake of 11,412 shares — an estimated $669 sold.

Jeff Yass first reported a position in NRXPW in Q4 2018 and held it in 10 quarters. The position peaked at $11K in Q4 2018. 2 funds tracked by Wall St. Rank hold NRXPW as of Q1 2026.

Jeff Yass reported no remaining NRX Pharmaceuticals Warrant position as of Q1 2026 after selling out during the quarter.
Jeff Yass sold 11,412 NRX Pharmaceuticals Warrant shares in Q1 2026, an estimated $669.
Jeff Yass first reported a position in NRX Pharmaceuticals Warrant in Q4 2018 and held it in 10 quarters.
Jeff Yass's NRX Pharmaceuticals Warrant position peaked at $11K in Q4 2018.
2 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.